Loading...
XMIL
BIE
Market cap908kUSD
, Last price  
EUR
Name

Bioera SpA

Chart & performance

D1W1MN
XMIL:BIE chart
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
96.67%
Rev. gr., 5y
-47.99%
Revenues
1m
-59.54%
33,368,00052,569,00076,636,000108,927,000116,595,000115,916,00069,787,00044,881,00045,728,00046,606,00051,680,00055,976,00052,922,00045,790,00039,210,00030,225,00010,334,000969,0003,688,0001,492,000
Net income
-3m
L-23.85%
1,017,0002,208,0001,019,000309,000-2,399,000-12,779,000-4,199,00011,358,000283,000-124,000-2,273,000-3,380,000-2,787,000-5,146,000-3,631,000-5,966,000-7,346,00036,731,000-4,113,000-3,132,000
CFO
-962k
L
-9,469,000-14,370,000-632,0004,391,0008,757,0003,749,000-912,0009,000-162,000-318,000-1,411,000-1,527,000-1,680,00034,0001,235,000-2,639,000-2,249,0004,167,000-962,000
Dividend
Jul 21, 20140.0073 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Bioera S.p.A., headquartered in Milan, Italy, since its establishment in 2004, specializes in the manufacturing and sale of organic goods, natural beauty items, and traditional food products throughout Italy. The company offers its range under the brand names KI, Crudigno, and Fonte della Vita, utilizing external partners for its distribution channels.

Key people

Davide Guerra
Head of Administration and Control, Financial Reporting Officer · since 2011
Silvia Garnero
Director · since 2017
Daniela Garnero Santanche
Chairman of the Board · since 2012
Michele Mario Mazzaro
Director · since 2015
Antonio Segni
Vice Chairman of the Board · since 2012
URL
http://www.bioera.it/it
IPO date
Jul 27, 2005
Employees
Domiciled in
IT
Incorporated in
IT
Headquarters & legal address
PIAZZALE LUIGI CADORNA, 4
MILANO, MI 20123
IT

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT